{"cluster": 48, "subcluster": 43, "abstract_summ": "We included studies reporting underlying CLD or elevated liver chemistries and patient outcomes in COVID-19.Background & Aims: Cumulating observations have indicated that COVID-19 patients undergo different patterns of abnormal liver chemistries.Background and Aims: Although abnormal liver chemistries are linked to higher risk of death related to coronavirus disease (COVID-19), liver manifestations may be diverse and even confused.COVID-19 patients with elevated liver chemistries had increased risk of mortality (OR-3.46 [2.42-4.95, P < 0.001]) and severe disease (OR-2.87 [95% CI, 2.29-3.6, P < 0.001]) compared to patients without elevated liver chemistries.Abstract: Background and Aim: With the increase in the number of COVID-19 infections, global health is facing insufficient sources; this study aimed to provide additional data regarding the clinical characteristics of patients diagnosed with COVID-19 and in particular to analyze the factors associated with disease severity, unimprovement and mortality.", "title_summ": "Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19.Liver Chemistries in Patients with Severe or Non-Severe COVID-19: a Meta-AnalysisPROGNOSTIC VALUE OF COMORMIDITY FOR SEVERITY OF COVID-19: A SYSTEMATIC REVIEW AND META-ANALYSIS STUDYLiver Chemistries in COVID-19 Patients with Survival or Death: A Meta-AnalysisSystematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infectionRisk of hepatic failure in COVID-19 patients.Cancer is associated with severe disease in COVID-19 patients: a systematic review and meta-analysisLiver profile in COVID-19: a meta-analysisA systematic review and meta-analysis of cancer patients affected by a novel coronavirusA systematic review and meta-analysis.", "title_abstract_phrases": "We included studies reporting underlying CLD or elevated liver chemistries and patient outcomes in COVID-19.Liver Chemistries in COVID-19 Patients with Survival or Death: A Meta-AnalysisBackground and Aims: Although abnormal liver chemistries are linked to higher risk of death related to coronavirus disease (COVID-19), liver manifestations may be diverse and even confused.Liver Chemistries in Patients with Severe or Non-Severe COVID-19: a Meta-AnalysisBackground & Aims: Cumulating observations have indicated that COVID-19 patients undergo different patterns of abnormal liver chemistries.PROGNOSTIC VALUE OF COMORMIDITY FOR SEVERITY OF COVID-19: A SYSTEMATIC REVIEW AND META-ANALYSIS STUDYAbstract: Background and Aim: With the increase in the number of COVID-19 infections, global health is facing insufficient sources; this study aimed to provide additional data regarding the clinical characteristics of patients diagnosed with COVID-19 and in particular to analyze the factors associated with disease severity, unimprovement and mortality.COVID-19 patients with elevated liver chemistries had increased risk of mortality (OR-3.46 [2.42-4.95, P < 0.001]) and severe disease (OR-2.87 [95% CI, 2.29-3.6, P < 0.001]) compared to patients without elevated liver chemistries."}